In the subgroup with ER expression <90%, DFS showed a trend of benefit in the group with AR/ER ≤ 1.00 compared with the group with AR/ER > 1.00, but there was no significant difference between the them ( p = 0.105).
← all excerpts
Correlation between Androgen Receptor Expression in Luminal B (HER-2 Negative) Breast Cancer and Disease Outcomes.
1
—
—